These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24558658)

  • 41. Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data.
    Costello SP; Conlon MA; Vuaran MS; Roberts-Thomson IC; Andrews JM
    Aliment Pharmacol Ther; 2015 Oct; 42(8):1011-8. PubMed ID: 26264455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fecal microbiota transplantation for Clostridium difficile infection: back to the future.
    Borgia G; Maraolo AE; Foggia M; Buonomo AR; Gentile I
    Expert Opin Biol Ther; 2015 Jul; 15(7):1001-14. PubMed ID: 26063385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Faecal microbiota transplantation for Clostridium difficile infection in the United Kingdom.
    Porter RJ; Fogg C
    Clin Microbiol Infect; 2015 Jun; 21(6):578-82. PubMed ID: 25677629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Faecal Microbiota Transplantation for Clostridium Difficile - a local perspective.
    Diamond C; McNeilly T
    Ulster Med J; 2017 May; 86(2):108-110. PubMed ID: 29535482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clostridium difficile Infection and Fecal Microbiota Transplant.
    Liubakka A; Vaughn BP
    AACN Adv Crit Care; 2016 Jul; 27(3):324-337. PubMed ID: 27959316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Harnessing microbiota to kill a pathogen: Fixing the microbiota to treat Clostridium difficile infections.
    Taur Y; Pamer EG
    Nat Med; 2014 Mar; 20(3):246-7. PubMed ID: 24603796
    [No Abstract]   [Full Text] [Related]  

  • 47. Faecal microbiota transplantation as salvage therapy for fulminant Clostridium difficile infections.
    Million M; Hocquart M; Seghboyan JM; Griffiths K; Halfon P; Lagier JC; Brouqui P; Raoult D
    Int J Antimicrob Agents; 2015 Aug; 46(2):227-8. PubMed ID: 26092095
    [No Abstract]   [Full Text] [Related]  

  • 48. Fecal microbiota transplantation in treating Clostridium difficile infection.
    Brown WR
    J Dig Dis; 2014 Aug; 15(8):405-8. PubMed ID: 24825534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Faecal microbiota transplantation in Clostridium difficile infections.
    Vigvári S; Nemes Z; Vincze Á; Solt J; Sipos D; Feiszt Z; Kovács B; Bartos B; Péterfi Z
    Infect Dis (Lond); 2015 Feb; 47(2):114-6. PubMed ID: 25623242
    [No Abstract]   [Full Text] [Related]  

  • 50. "Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year cohort study"; methodological issues.
    Ayubi E; Safiri S
    Clin Microbiol Infect; 2017 Nov; 23(11):890. PubMed ID: 28442436
    [No Abstract]   [Full Text] [Related]  

  • 51. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Faecal microbiota transplant - prospects and safety.
    Bartnicka A; Szachta P; Gałecka M
    Pomeranian J Life Sci; 2015; 61(3):282-6. PubMed ID: 27344870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Giving Microbiome: Share the Health.
    Pitashny M
    Isr Med Assoc J; 2016 Oct; 18(10):623-624. PubMed ID: 28471624
    [No Abstract]   [Full Text] [Related]  

  • 54. Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature.
    Lin SC; Alonso CD; Moss AC
    Transpl Infect Dis; 2018 Dec; 20(6):e12967. PubMed ID: 30011107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.
    Cammarota G; Ianiro G; Gasbarrini A
    J Clin Gastroenterol; 2014 Sep; 48(8):693-702. PubMed ID: 24440934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection.
    Quera R; Espinoza R; Estay C; Rivera D
    J Crohns Colitis; 2014 Mar; 8(3):252-3. PubMed ID: 24184170
    [No Abstract]   [Full Text] [Related]  

  • 57. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
    Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
    Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Editorial: Making Fecal Microbiota Transplantation Easier to Swallow: Freeze-Dried Preparation for Recurrent Clostridium difficile Infections.
    Youngster I; Gerding DN
    Am J Gastroenterol; 2017 Jun; 112(6):948-950. PubMed ID: 28572645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.
    Costello SP; Tucker EC; La Brooy J; Schoeman MN; Andrews JM
    Clin Infect Dis; 2016 Apr; 62(7):908-14. PubMed ID: 26628567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fecal microbiota transplantation for treating recurrent Clostridium difficile infection.
    Manag Care; 2013 Jun; 22(6):18-9. PubMed ID: 23841136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.